A federal lawsuit challenging FDA rules allowing telehealth and mail delivery access to the abortion pill mifepristone could further restrict abortion access in Georgia, where 68% of abortion patients in 2022 were Black. Since Georgia's six-week abortion ban took effect, telehealth has become a key method for obtaining abortion care, especially for Black residents, and any limitations on this access may worsen the state's high Black maternal mortality rate.
Read →Loading search…